Dynavax Technologies
DVAX
#4922
Rank
S$2.31 B
Marketcap
S$19.71
Share price
0.06%
Change (1 day)
11.34%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: S$2.31 Billion

As of February 2026 Dynavax Technologies has a market cap of S$2.31 Billion. This makes Dynavax Technologies the world's 4922th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.31 B-0.17%
2025S$2.31 B-0.18%
2024S$2.32 B-2.67%
2023S$2.38 B31.14%
2022S$1.81 B-20.24%
2021S$2.28 B251.73%
2020S$0.64 B0.3%
2019S$0.64 B-17.69%
2018S$0.78 B-48.15%
2017S$1.51 B588.1%
2016S$0.22 B-83.24%
2015S$1.31 B124.19%
2014S$0.58 B-10.2%
2013S$0.65 B2.44%
2012S$0.63 B16.85%
2011S$0.54 B14.41%
2010S$0.47 B340.4%
2009S$0.10 B126.02%
2008S$47.87 M-83.63%
2007S$0.29 B-47.7%
2006S$0.55 B236.89%
2005S$0.16 B-46.29%
2004S$0.30 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Dynavax Technologies was reported to be:

S$2.31 Billion
by Nasdaq info icon info icon
S$2.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$191.91 B 8,190.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$236.09 B 10,099.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$33.62 B 1,352.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$225.35 B 9,635.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$357.29 B 15,335.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$751.53 B 32,366.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$134.62 B 5,715.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
S$0.13 B-94.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.02 B 2,104.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel